UBS Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164M | Sell |
|
|||||
|
2025
Q1 | $190M | Buy |
|
|||||
|
2024
Q4 | $165M | Buy |
|
|||||
|
2024
Q3 | $158M | Sell |
|
|||||
|
2024
Q2 | $147M | Sell |
|
|||||
|
2024
Q1 | $150M | Sell |
|
|||||
|
2023
Q4 | $168M | Sell |
|
|||||
|
2023
Q3 | $189M | Buy |
|
|||||
|
2023
Q2 | $181M | Sell |
|
|||||
|
2023
Q1 | $173M | Sell |
|
|||||
|
2022
Q4 | $189M | Sell |
|
|||||
|
2022
Q3 | $178M | Sell |
|
|||||
|
2022
Q2 | $220M | Sell |
|
|||||
|
2022
Q1 | $279M | Sell |
|
|||||
|
2021
Q4 | $366M | Sell |
|
|||||
|
2021
Q3 | $369M | Sell |
|
|||||
|
2021
Q2 | $434M | Sell |
|
|||||
|
2021
Q1 | $430M | Sell |
|
|||||
|
2020
Q4 | $522M | Sell |
|
|||||
|
2020
Q3 | $578M | Sell |
|
|||||
|
2020
Q2 | $590M | Sell |
|
|||||
|
2020
Q1 | $610M | Sell |
|
|||||
|
2019
Q4 | $765M | Buy |
|
|||||
|
2019
Q3 | $662M | Sell |
|
|||||
|
2019
Q2 | $715M | Sell |
|
|||||
|
2019
Q1 | $682M | Buy |
|
|||||
|
2018
Q4 | $585M | Buy |
|
|||||
|
2018
Q3 | $575M | Buy |
|
|||||
|
2018
Q2 | $497M | Buy |
|
|||||
|
2018
Q1 | $527M | Buy |
|
|||||
|
2017
Q4 | $523M | Buy |
|
|||||
|
2017
Q3 | $528M | Sell |
|
|||||
|
2017
Q2 | $519M | Buy |
|
|||||
|
2017
Q1 | $445M | Buy |
|
|||||
|
2016
Q4 | $410M | Buy |
|
|||||
|
2016
Q3 | $438M | Buy |
|
|||||
|
2016
Q2 | $448M | Buy |
|
|||||
|
2016
Q1 | $377M | Buy |
|
|||||
|
2015
Q4 | $422M | Sell |
|
|||||
|
2015
Q3 | $458M | Sell |
|
|||||
|
2015
Q2 | $504M | Buy |
|
|||||
|
2015
Q1 | $498M | Buy |
|
|||||
|
2014
Q4 | $452M | Buy |
|